Could lack of vitamin D be behind Sids cases? (BBC Radio 4 Today Programme, 26 January 2012)

Diabetes drugs tied to pancreatic cancer risk (Reuters, 31 January 2012)

Amylin's long-delayed diabetes drug gets US nod (Associated Press, 28 January 2012)

01 Feb 2012

The US Food and Drug Administration has approved the long-acting GLP-1 agonist Bydureon for the treatment of type 2 diabetes mellitus.

Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story

Top stories

Call for nominations for Awards Committee Chair
30 Oct 2024

James M Tanner Award - 2025 nominations open
30 Oct 2024

Would you like to host the BSPED annual meeting?
21 Oct 2024

Most read